Indeterminate FIB-4 Result (1.3–2.67): The Australian GP's Next Step
Your patient's FIB-4 score is between 1.3 and 2.67. Here is the evidence-based next step for Australian GPs managing MAFLD and metabolic risk.
Content note
Prepared by the Elastography Australia clinical education team for informational purposes. This content does not replace clinician judgement or individual medical advice.
The three FIB-4 zones
FIB-4 is a triage tool. It is excellent at ruling out advanced fibrosis (low risk) and flagging high-risk cases for immediate specialist referral. The challenge lies in the middle.
- <1.3 (Low risk): Reassure and monitor. Repeat in 1-3 years depending on metabolic risk factors.
- 1.3–2.67 (Indeterminate): The grey zone. Elastography is required to confirm or rule out significant fibrosis.
- >2.67 (High risk): High probability of advanced fibrosis. Specialist referral and further investigation recommended.
What Australian guidelines (GESA) recommend
GESA guidelines for MAFLD explicitly position elastography as the required second-line test when FIB-4 is indeterminate. You do not need to refer to a hepatologist immediately — you need a liver stiffness measurement (LSM).
Depending on the elastography result, the patient can often remain in primary care for lifestyle intervention and monitoring.
Worked clinical example
Consider a 52-year-old male with type 2 diabetes, BMI 32, and mild ALT elevation. You calculate a FIB-4 score of 1.8.
Because he is in the indeterminate zone (1.3–2.67), you order or perform a guided liver elastography scan. The scan returns a stiffness of 5.8 kPa (F0-F1, low risk) but a high UAP score (severe steatosis).
Outcome: You avoid an unnecessary specialist referral. You manage his steatosis and metabolic risk in primary care, and schedule a repeat elastography scan in 2 years to ensure his fibrosis isn't progressing.
kPa threshold interpretation
Once you have the elastography result, the general interpretation thresholds (which vary slightly by etiology) are:
- <8.0 kPa: Low risk of advanced fibrosis. Manage in primary care.
- 8.0–12.0 kPa: Grey zone / moderate risk. Consider specialist review or close monitoring.
- >12.0 kPa: High risk of advanced fibrosis/cirrhosis. Refer to hepatology.
Why guided elastography matters here
Many patients in the indeterminate FIB-4 group have a high BMI. Traditional blind elastography (like standard FibroScan models) often fails or returns unreliable results in obese patients because the skin-to-liver distance is too great.
Guided elastography uses real-time 2D ultrasound to ensure the measurement is taken in the correct location, dramatically reducing failure rates and giving GPs confidence in the result.